ArticleLife (Basel, Switzerland)2025

Redefining Systemic Sclerosis Classification: Anti-Topoisomerase Antibody as a Superior Predictor of Interstitial Lung Disease and Skin Progression Compared to Limited Cutaneous Systemic Sclerosis Subset.

Chana Chaovanitkul et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.